MetaCap

BrightSpring Health Services Inc. (BTSG)

NASDAQ: BTSGHealth CareMedical/Nursing ServicesUSD

62.89-1.13 (-1.77%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BTSG stock chart

Technical analysis

Key statistics

All statistics
Market cap
$12.51B
52-week range
34.30 – 73.75
Day range
61.85 – 64.47
Volume / Avg
3.31M / 2.49M
Beta
—

52-week range

$34.30$73.75

BTSG stock today

BrightSpring Health Services (BTSG) closed at $62.89 on Nov 20, down 1.77% (-$1.13), versus the S&P 500's 3.70% decline. At this level, BTSG sits in the middle of its 52-week range of $34.30 to $73.75: 14.7% below the high, set on Jul 27, 2026 and 83.4% above the low. BTSG is up 67.8% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 81.7%.

At 44.6x trailing earnings, BrightSpring Health Services trades above the peer-group median of 24.6x. Its forward P/E of 25.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About BrightSpring Health Services

Company profile

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services.

Industry
Medical/Nursing Services
CEO
Mr. Jon B. Rousseau
Headquarters
Louisville, KY
Employees
23,500
IPO year
2024

Financial highlights

Full financials

In fiscal 2025, BrightSpring Health Services generated $12.91 billion in revenue, up 28.2% from fiscal 2024, its 2nd consecutive year of revenue growth. Net income was $190.7 million, for a net margin of 1.5% versus a median of -0.7% in the prior 3 years. Gross margin was 11.8% (down from 12.6%) and operating margin 2.3%.

BrightSpring Health Services annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$12.91B$10.07B$7.69B$7.72B
Growth+28.18%+30.96%-0.38%—
Net income$190.67M$-18.06M$-154.60M$-53.91M
EPS (diluted)$0.87$-0.09$-1.31$-0.46

Analyst forecast

Forecast

Consensus (18 analysts)

strong_buy

Avg. price target

$83.44+32.68%

  • Strong buy 3
  • Buy 15
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $73.50High $92.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 30, 2026
EPS actual vs est.
$0.45 vs $0.45

BTSG news

All BTSG news

BrightSpring Health Services peers

Health Care sector
BTSG peer companies
CompanyPrice% ChgMarket capCompare
CHEChemed Corp548.59-0.50%$7.11Bvs BTSG
LFSTLifeStance Health Group Inc.13.82+3.60%$5.25Bvs BTSG
OPCHOption Care Health Inc.31.59-0.06%$4.73Bvs BTSG
HIMSHims & Hers Health Inc. Class A14.60-8.86%$3.42Bvs BTSG
PRVAPrivia Health Group Inc.25.05+1.46%$3.20Bvs BTSG
AVAHAveanna Healthcare Holdings Inc.11.01+2.90%$2.40Bvs BTSG
ADUSAddus HomeCare Corporation122.50+1.18%$2.28Bvs BTSG
USPHU.S. Physical Therapy Inc.95.93+1.71%$1.43Bvs BTSG

Indexes, lists and sector

BrightSpring Health Services stock FAQ

What is BrightSpring Health Services's stock price today?

BTSG last traded at $62.89 as of Nov 20, 4:00 PM EST, down 1.77% on the day. Prices are delayed at least 15 minutes.

What is BTSG's P/E ratio?

BTSG trades at a trailing P/E ratio of 44.60 and a forward P/E of 25.89, compared with a median of 24.6 for its closest peers.

Who is BrightSpring Health Services's CEO?

Mr. Jon B. Rousseau is the chief executive officer of BrightSpring Health Services Inc., which has about 23,500 employees.

What is the BTSG 52-week high?

The 52-week high for BTSG is $73.75 and the 52-week low is $34.30. The stock is currently 14.7% below its high.

Compare BTSG